Loading publications…
The last 5 uploaded publications
Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma
Sarah Cappuyns, Virginia Corbett, Mark Yarchoan, Richard S. Finn, Josep M. Llovet (2023). Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma. JAMA Oncology, 10(3), pp. 395-395, DOI: 10.1001/jamaoncol.2023.2677.
Article145 days agoImpact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors
Linda Y. Wu, Sarah Cappuyns, Amanda S. Loh, Sean Sun, Sara Lewis, Max W. Sung, Myron Schwartz, Josep M. Llovet, Deirdre Jill Cohen (2024). Impact of underlying liver disease on unresectable hepatocellular carcinoma treated with immune checkpoint inhibitors. BJC Reports, 2(1), DOI: 10.1038/s44276-024-00038-w.
Article145 days agoOncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC
Marta Piqué‐Gili, Carmen Andreu-Oller, Agavni Mesropian, Roger Esteban-Fabró, Marina Bárcena‐Varela, Marina Ruiz de Galarreta, Carla Montironi, Iris Martinez-Quetglas, Sarah Cappuyns, Judit Peix, Ieva Keraite, Albert Gris‐Oliver, Elisa Fernández-Martínez, Ezequiel Mauro, Miguel Torres‐Martín, Jordi Abril‐Fornaguera, Katherine E. Lindblad, Diether Lambrechts, Jeroen Dekervel, Swan N. Thung, Daniela Sia, Amaia Lujambio, Roser Pinyol, Josep M. Llovet (2024). Oncogenic role of PMEPA1 and its association with immune exhaustion and TGF-β activation in HCC. JHEP Reports, 6(11), pp. 101212-101212, DOI: 10.1016/j.jhepr.2024.101212.
Article145 days agoSingle-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma
Sarah Cappuyns, Marta Piqué‐Gili, Roger Esteban-Fabró, Gino Philips, Ugne Balaseviciute, Roser Pinyol, Albert Gris‐Oliver, Vincent Vandecaveye, Jordi Abril‐Fornaguera, Carla Montironi, Laia Bassaganyas, Judit Peix, Marcus Zeitlhöfler, Agavni Mesropian, Júlia Huguet‐Pradell, Philipp K. Haber, Igor Figueiredo, Giorgio Ioannou, Edgar Gonzalez‐Kozlova, Antonio D’Alessio, Raphael Mohr, Tim Meyer, Anja Lachenmayer, Jens U. Marquardt, Helen L. Reeves, Julien Edeline, Fabian Finkelmeier, Jörg Trojan, Peter R. Galle, Friedrich Foerster, Beatriz Mínguez, Robert Montal, Sacha Gnjatic, David J. Pinato, Mathias Heikenwälder, Chris Verslype, Eric Van Cutsem, Diether Lambrechts, Augusto Villanueva, Jeroen Dekervel, Josep M. Llovet (2024). Single-cell RNA seq-derived signatures define response patterns to atezolizumab + bevacizumab in advanced hepatocellular carcinoma. Journal of Hepatology, DOI: 10.1016/j.jhep.2024.12.016.
Article145 days agoCombination Therapies for Advanced Hepatocellular Carcinoma: Biomarkers and Unmet Needs
Sarah Cappuyns, Josep M. Llovet (2022). Combination Therapies for Advanced Hepatocellular Carcinoma: Biomarkers and Unmet Needs. Clinical Cancer Research, 28(16), pp. 3405-3407, DOI: 10.1158/1078-0432.ccr-22-1213.
Letter145 days ago